Featured Articles
-
Case Study: How To Enroll 612 Patients in a Neurology Study On Time And Within Budget Despite Hurdles Caused By The Pandemic
2/16/2022
In June 2020 Dr. Reddy's, a leading Indian pharmaceutical manufacturer, in partnership with OCT Clinical, an Eastern European CRO, launched a Ph3 neurology study. Despite pandemic-driven uncertainty, the enrollment target of 612 patients was reached within an impressive seven months, two weeks ahead of schedule.
This website uses cookies to ensure you get the best experience on our website. Learn more